U.S. General Merchandise and Department Stores Stock News

On July 13, 2026, Shutterstock, Inc. announced that Chief Executive Officer and longtime board member Paul Hennessy stepped down, with Chief Financial Officer Rik Powell assuming the role of Interim CEO while retaining his CFO responsibilities during the transition. This leadership change comes just days after Getty Images canceled its planned merger with Shutterstock following UK regulators’ requirement that Shutterstock divest its editorial business, leaving the company to reset its...

Vor Biopharma recently appointed David Zaccardelli, Pharm.D., to its Board of Directors, adding a leader who has guided multiple biopharmaceutical companies through late-stage development, regulatory approvals, commercial launches, and acquisitions, including Verona Pharma’s US$10 billion sale to Merck in 2025. His track record in advancing therapies from clinical programs to approved products and in raising over US$1 billion for development and commercialization efforts introduces...

Texas Capital Bancshares (NasdaqGS:TCBI) has appointed Mo Jamous as Managing Director, Chief Digital and Information Officer. Jamous is set to lead the company's technological transformation, including digital banking, technology infrastructure, and AI driven solutions. He brings experience in digital banking and AI enablement from prior roles at U.S. Bank and BBVA. For Texas Capital Bancshares, a commercial and consumer banking company, this leadership change comes as digital channels and...

Allegro MicroSystems recently launched the A81415, described as the industry's first ASIL-D-certified power management IC that integrates a wheel-speed sensor interface, aiming to simplify electromechanical braking and next-generation brake-by-wire designs. By combining power regulation, wheel-speed signal decoding, and support for Allegro’s XtremeSense TMR sensors in one chip, the A81415 seeks to cut component count, free up more than half of the brake-caliper board space, and trim latency...

Ligand Pharmaceuticals (LGND) has completed its approximately US$739 million cash acquisition of XOMA Royalty Corporation, adding seven commercial products and more than 100 development and commercial stage assets to its royalty portfolio of more than 200 assets. See our latest analysis for Ligand Pharmaceuticals. Ligand Pharmaceuticals’ latest move comes after a strong run in the stock, with the share price up 55.84% year to date and supported by a 128.54% 1 year total shareholder return...

Insulet stock has fallen sharply over the past year, yet on current market multiples it still screens as expensive. This leaves investors weighing a weak share price record against valuation checks that do not flag a clear bargain. Insulet has declined 44.7% over the last 12 months, which means the stock has given back a large amount of value despite more recent short term gains. Product quality issues and related recalls around the Omnipod franchise can weigh on sentiment, while ongoing...

Opera reported that in the second quarter its combined monthly active users on Android and iOS browsers grew 66% in the UK and 40% in the US year over year, helped by the EU's 2024 Digital Markets Act opening up browser choice on iOS. This surge highlights how regulatory change, paired with Opera’s built-in AI, unlimited VPN and improved cross-device sync, can meaningfully shift user behavior in mature mobile markets. Against this backdrop, we’ll examine how Opera’s rapid mobile user growth,...

Markel Insurance, part of Markel Group (NYSE:MKL), appointed Marc Copland as Vice President, Product Line Leader, Property in Canada. Copland will focus on expanding Markel Canada's Property portfolio and using technology to support product development. The role is intended to reinforce Markel Canada's position in the specialty insurance market. For shareholders watching how Markel Group positions its insurance operations, this appointment highlights attention on the Canadian Property...

Illumina expanded its Billion Cell Atlas alliance with three new members, including AI-first drug developer Formation Bio. The alliance aims to build and share what is described as the world's largest genomic perturbation data set. The expansion is intended to speed up AI-driven drug discovery and target validation through large-scale genomic collaboration. For investors watching Illumina (NasdaqGS: ILMN), this alliance update adds a fresh angle to a stock that has recently shown strong...

Rocket Companies stock has delivered a 43.4% return over the past 3 years, yet the current checks present a mixed valuation picture where the Excess Returns intrinsic value estimate points to a roughly fair price while the market multiples suggest the shares may still be on the cheap side. Over 3 years, Rocket Companies has returned 43.4%, which puts recent share performance firmly in positive territory for longer term holders. The scale of Rocket’s $2.1b servicing portfolio, along with...

Tariff policy is back in the spotlight after the Supreme Court ruling on emergency tariff powers and the approaching expiry of current Section 122 tariffs. For domestic manufacturing and industrial stocks, this mix of lost tariff revenue, possible Section 301 actions, and extended uncertainty around global trade could reshape where capital and risk sit. This article looks at three U.S. based companies from a Domestic Manufacturing and Industrial Stocks screener that are closely exposed to...

Recently, Werner Enterprises received a Zacks Rank #2 rating after analysts raised their earnings estimates, reflecting growing optimism about the company’s earnings outlook. This shift in expectations comes despite earlier concerns about weaker sales and profitability, highlighting how analyst sentiment can change the perceived risk profile of the business. Now, we will explore how these upgraded earnings expectations reshape Werner’s existing investment narrative built around capacity...

Earlier this week, Zacks upgraded Figs (FIGS) to a Rank #2 rating, citing an upward trend in analyst earnings estimate revisions and growing optimism around the company’s earnings outlook. This shift in analyst sentiment highlights how changes in earnings expectations alone can materially influence perceptions of FIGS’ underlying business momentum. With this earnings-estimate upgrade in mind, we’ll now examine how the changed outlook could interact with FIGS’ existing margin-recovery...

Constellium (NYSE:CSTM) has entered into a 10-year Power Purchase Agreement for solar electricity for its Gottmadingen and Singen plants in Germany. The agreement is expected to cover more than a quarter of the sites’ electricity needs and support annual CO₂ emissions reductions. The deal is part of Constellium’s broader sustainability approach and aims to support energy resilience and competitiveness in Germany. Constellium, a supplier of aluminum products and solutions, is tying a...

Ventas (NYSE:VTR) has raised its annualized dividend rate, an 8.3% increase from last year. The new payout level reflects recent board action and updates the income profile for current and prospective shareholders. The change arrives as the company reports projected earnings improvements that support higher dividend distributions. Ventas operates as a real estate investment trust focused on healthcare properties, an area closely watched by income oriented investors. In this corner of the...

TD SYNNEX has been named an approved global distributor for Fortinet, expanding its role in cybersecurity distribution worldwide. The agreement gives TD SYNNEX broader reach with global systems integrators and large international partners. The new status is expected to support multi region Fortinet deployments and centralized support for enterprise customers. TD SYNNEX (NYSE:SNX), currently trading at $250.08, has seen a strong run in its stock, with the share price up 63.0% year to date...

Oceaneering International stock has delivered a strong 214.1% return over the past five years, yet current valuation checks suggest the shares are trading at a premium, with both market multiples and an intrinsic value estimate pointing in the same direction. Over the last 5 years, Oceaneering International has returned 214.1%, which puts extra focus on whether today’s price already reflects much of that improvement. Winning a role in the U.S. Defense Innovation Unit’s undersea vehicle...

BILL Holdings has seen its share price fall about 78% over the past five years, yet the current checks suggest the stock now screens cheaply, creating a clear tension between a weak long term track record and a more appealing valuation setup today. The roughly 77.7% decline over five years leaves long term holders deeply underwater, which makes the current rebound phase especially important for anyone reassessing entry or exit levels. Fresh optimism around earnings prospects and leadership...

Cheniere Energy (NYSE:LNG) has appointed former McKesson CFO Britt Vitalone as an independent director. The move increases the size of Cheniere Energy's board and adds extensive financial and audit experience. Vitalone brings boardroom expertise in capital allocation, transaction oversight, and large company operations. Cheniere Energy is a major US liquefied natural gas exporter, operating at the intersection of global energy demand and long term LNG supply contracts. The addition of Britt...

Take-Two Interactive Software (TTWO) is back in focus after a recent share price decline and a Zacks Rank of #4 (Sell), as analysts trim earnings estimates ahead of the August 7, 2026 report. See our latest analysis for Take-Two Interactive Software. Take-Two Interactive Software’s recent pullback comes after analysts cut earnings expectations. However, the stock still shows a 12.75% 1 month share price return and a 60.38% 3 year total shareholder return, which may indicate that longer term...

NextDecade stock has delivered a strong 119.3% return over the past five years, yet its low value score suggests the current share price of US$7.61 may not stand out as a clear bargain based on broader valuation checks. Over five years, NextDecade has returned 119.3%, which puts the recent volatility into the context of a longer term upswing for existing holders. The planned Rio Grande LNG project, which aims to position NextDecade as a major US LNG exporter, can support investor...

The FDA’s decision to lift clinical holds on Intellia Therapeutics (NTLA)’s MAGNITUDE and MAGNITUDE-2 trials has refocused attention on the stock, as patient enrollment for its in vivo CRISPR programs can now continue. See our latest analysis for Intellia Therapeutics. Despite the regulatory relief, Intellia Therapeutics’ 1-day share price return declined 1.95% to US$13.04, extending a 7-day share price decline of 22.57%. However, the year to date share price return of 41.59% contrasts with a...

In recent days, Affirm Holdings reported quarterly revenue of US$1.04 billion and net profit of US$102.9 million, while Bed Bath & Beyond enabled Affirm installments across its brands. This combination of improving profitability, fresh merchant adoption and ongoing debate over leverage and capital efficiency has sharpened focus on Affirm’s business quality. We’ll now examine how Affirm’s move into Bed Bath & Beyond’s checkout, alongside profitability gains, influences its existing...

Doximity (DOCS) is back in focus after reporting that its HIPAA compliant clinical AI tool, Doximity Ask, ranked first for safety in the independent NOHARM benchmark run by Stanford and Harvard physicians. See our latest analysis for Doximity. Doximity’s share price has shown a short burst of strength, with a 1 month share price return of 7.64% and a 7 day share price return of 2.63%. However, this follows a much weaker period where the year to date share price return is down 48.58% and the 1...